Therapeutic strategies targeting synovial cells to treat osteoarthritis

Area of Science:

• Rheumatology
• Cell Biology
• Biomedical Science

Background:

• Osteoarthritis (OA) is a debilitating joint disease with no cure, necessitating novel therapeutic approaches.
• Synovial cells, including macrophages and fibroblasts, are key players in OA pathogenesis.
• Synovial macrophages polarize to a pro-inflammatory M1 phenotype, while fibroblasts exhibit abnormal activation, contributing to OA progression.

Purpose of the Study:

• To review the critical roles of synovial cells in osteoarthritis.
• To explore the potential of targeting synovial cells for OA treatment.
• To discuss current and innovative therapeutic strategies for OA management.

Main Methods:

• Literature review of studies on synovial cells in osteoarthritis.
• Analysis of cellular mechanisms involved in OA pathogenesis.
• Evaluation of therapeutic strategies targeting synovial cells.

Main Results:

• Synovial macrophages and fibroblasts significantly contribute to OA development and progression.
• Modulating synovial macrophage polarization and fibroblast activation are promising therapeutic avenues.
• Targeting synovial cells in vivo presents a viable strategy for OA management.

Conclusions:

• Understanding synovial cell behavior is crucial for developing effective OA treatments.
• Regulating synovial macrophages and fibroblasts holds potential for counteracting OA progression.
• Innovative therapies targeting synovial cells offer hope for managing osteoarthritis.